Skip to main
SBTX

Silverback Therapeutics (SBTX) Market Capitalization Overview

Market Cap: $1.16B as of Dec 30, 2025

$1.16B
$207.59M (22.01%)past month
As of Dec 30, 2025, Silverback Therapeutics (SBTX) has a market capitalization of $1.16B. Over the past 30 days, its market cap has increased by 9.07%, while in the last 12 months, it has increased by 12.22%.

Market capitalization represents the total value of Silverback Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Silverback Therapeutics (SBTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Silverback Therapeutics (SBTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Silverback Therapeutics (SBTX) Market Cap History

DateMarket CapChange
Dec 1, 2025$929.18M+9.07%
Nov 3, 2025$851.89M-14.57%
Oct 1, 2025$997.16M-9.26%
Sep 2, 2025$1.10B-34.87%
Aug 1, 2025$1.69B+6.77%
Jul 1, 2025$1.59B+11.27%
Jun 2, 2025$1.43B+2.22%
May 1, 2025$1.39B+13.01%
Apr 1, 2025$1.23B+24.27%
Mar 3, 2025$989.35M-17.30%
Feb 3, 2025$1.20B+14.94%
Jan 2, 2025$1.05B-19.59%

Silverback Therapeutics (SBTX) End of Year Market Cap History

DateMarket CapChange
2025$1.16B+12.22%
2024$1.03B+94.90%
2023$526.07M+71.04%
2022$307.58M+31.66%
2021$233.61M

FAQs About Silverback Therapeutics (SBTX) Market Cap

As of Dec 30, 2025, the market capitalization of Silverback Therapeutics (SBTX) is $1.16B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Silverback Therapeutics’s market capitalization has increased by 22.01%, changing from $943.02M to $1.16B as of Dec 30, 2025.

In the last 3 months, Silverback Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Silverback Therapeutics’s market capitalization increased from $526.07M in January to $1.03B in December, reflecting a 94.9% change.

In the past five years, Silverback Therapeutics (SBTX) has had a compound annual growth rate (CAGR) of 44.74% in market capitalization. This means its market cap has grown at an average rate of 44.74% per year.

Silverback Therapeutics (SBTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.